When doctors talk about BCMA, B-cell maturation antigen, a protein found on the surface of certain immune cells that becomes a target in cancer treatment. Also known as B-cell maturation antigen, it plays a critical role in the survival of plasma cells — and when those cells turn cancerous, BCMA becomes a bullseye for new treatments. This isn’t just another biological marker. BCMA is the reason why patients with advanced multiple myeloma now have options where none existed a decade ago.
Multiple myeloma feeds on BCMA. Cancerous plasma cells overproduce this protein, using it to stay alive and multiply. That’s why drugs designed to latch onto BCMA — like CAR-T cell therapies and antibody-drug conjugates — are turning the tide. Treatments like belantamab mafodotin and idecabtagene vicleucel don’t just attack cancer randomly. They hunt down cells wearing BCMA like a flag. This precision means fewer side effects than traditional chemo and better survival rates for people who’ve run out of other options. BCMA-targeted therapy isn’t experimental anymore. It’s standard care in many clinics, especially for relapsed or refractory cases.
But BCMA isn’t just about drugs. It’s also a diagnostic clue. High levels of BCMA in the blood often mean the cancer is active or growing. Doctors now track it like a thermometer for myeloma. And because BCMA expression can change over time, researchers are testing combo therapies to keep the target visible to treatments. Newer approaches even combine BCMA-targeting agents with immune boosters to help the body stay in the fight longer.
What you’ll find in the articles below isn’t a list of random medical facts. It’s a focused collection of real-world guides on treatments that target BCMA and related pathways. You’ll see comparisons of new drugs, insights into how they’re used in practice, and what patients actually experience. Whether you’re a patient, caregiver, or just trying to understand why BCMA is in the news so often, this collection cuts through the noise. These aren’t theory papers — they’re practical breakdowns of what’s working today, who it helps, and how it’s changing the game.
Nov, 17 2025
Barcode scanning in pharmacies prevents up to 93% of medication errors by verifying the right patient, drug, dose, route, and time. Learn how it works, where it fails, and why it's still the gold standard for safety.